nodes	percent_of_prediction	percent_of_DWPC	metapath
Methylprednisolone—ABCB1—Mitomycin—stomach cancer	0.27	0.483	CbGbCtD
Methylprednisolone—ABCB1—Irinotecan—stomach cancer	0.0692	0.124	CbGbCtD
Methylprednisolone—ABCB1—Docetaxel—stomach cancer	0.0507	0.0908	CbGbCtD
Methylprednisolone—CYP3A4—Irinotecan—stomach cancer	0.0414	0.0742	CbGbCtD
Methylprednisolone—ABCB1—Doxorubicin—stomach cancer	0.0378	0.0677	CbGbCtD
Methylprednisolone—ABCB1—Methotrexate—stomach cancer	0.0366	0.0656	CbGbCtD
Methylprednisolone—CYP3A4—Docetaxel—stomach cancer	0.0304	0.0544	CbGbCtD
Methylprednisolone—CYP3A4—Doxorubicin—stomach cancer	0.0226	0.0406	CbGbCtD
Methylprednisolone—Medroxyprogesterone Acetate—AKR1C3—stomach cancer	0.00139	0.263	CrCbGaD
Methylprednisolone—Hydrocortisone—ANXA1—stomach cancer	0.00129	0.243	CrCbGaD
Methylprednisolone—Dexamethasone—ANXA1—stomach cancer	0.000961	0.181	CrCbGaD
Methylprednisolone—Prednisolone—CYP2A6—stomach cancer	0.000517	0.0977	CrCbGaD
Methylprednisolone—Malaise—Capecitabine—stomach cancer	0.000315	0.000821	CcSEcCtD
Methylprednisolone—Vertigo—Capecitabine—stomach cancer	0.000313	0.000818	CcSEcCtD
Methylprednisolone—Hypersensitivity—Irinotecan—stomach cancer	0.000313	0.000818	CcSEcCtD
Methylprednisolone—Syncope—Capecitabine—stomach cancer	0.000313	0.000816	CcSEcCtD
Methylprednisolone—Convulsion—Docetaxel—stomach cancer	0.000312	0.000815	CcSEcCtD
Methylprednisolone—Hypertension—Docetaxel—stomach cancer	0.000311	0.000812	CcSEcCtD
Methylprednisolone—Infestation NOS—Epirubicin—stomach cancer	0.000311	0.000811	CcSEcCtD
Methylprednisolone—Infestation—Epirubicin—stomach cancer	0.000311	0.000811	CcSEcCtD
Methylprednisolone—Myalgia—Docetaxel—stomach cancer	0.000307	0.0008	CcSEcCtD
Methylprednisolone—Arthralgia—Docetaxel—stomach cancer	0.000307	0.0008	CcSEcCtD
Methylprednisolone—Loss of consciousness—Capecitabine—stomach cancer	0.000307	0.0008	CcSEcCtD
Methylprednisolone—Asthenia—Irinotecan—stomach cancer	0.000305	0.000796	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Epirubicin—stomach cancer	0.000305	0.000795	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000305	0.000795	CcSEcCtD
Methylprednisolone—Hypertension—Capecitabine—stomach cancer	0.000301	0.000786	CcSEcCtD
Methylprednisolone—Hypersensitivity—Fluorouracil—stomach cancer	0.0003	0.000783	CcSEcCtD
Methylprednisolone—Haemoglobin—Methotrexate—stomach cancer	0.0003	0.000782	CcSEcCtD
Methylprednisolone—Haemorrhage—Methotrexate—stomach cancer	0.000298	0.000778	CcSEcCtD
Methylprednisolone—Sweating—Epirubicin—stomach cancer	0.000298	0.000778	CcSEcCtD
Methylprednisolone—Arthralgia—Capecitabine—stomach cancer	0.000297	0.000775	CcSEcCtD
Methylprednisolone—Myalgia—Capecitabine—stomach cancer	0.000297	0.000775	CcSEcCtD
Methylprednisolone—Confusional state—Docetaxel—stomach cancer	0.000296	0.000774	CcSEcCtD
Methylprednisolone—Anxiety—Capecitabine—stomach cancer	0.000296	0.000772	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000295	0.00077	CcSEcCtD
Methylprednisolone—Dexamethasone—CYP2A6—stomach cancer	0.000295	0.0557	CrCbGaD
Methylprednisolone—Anaphylactic shock—Docetaxel—stomach cancer	0.000294	0.000767	CcSEcCtD
Methylprednisolone—Weight increased—Doxorubicin—stomach cancer	0.000294	0.000766	CcSEcCtD
Methylprednisolone—Discomfort—Capecitabine—stomach cancer	0.000293	0.000766	CcSEcCtD
Methylprednisolone—Infection—Docetaxel—stomach cancer	0.000292	0.000762	CcSEcCtD
Methylprednisolone—Diarrhoea—Irinotecan—stomach cancer	0.000291	0.000759	CcSEcCtD
Methylprednisolone—Shock—Docetaxel—stomach cancer	0.000289	0.000755	CcSEcCtD
Methylprednisolone—Nervous system disorder—Docetaxel—stomach cancer	0.000288	0.000752	CcSEcCtD
Methylprednisolone—Pruritus—Fluorouracil—stomach cancer	0.000288	0.000752	CcSEcCtD
Methylprednisolone—Infestation NOS—Doxorubicin—stomach cancer	0.000288	0.000751	CcSEcCtD
Methylprednisolone—Infestation—Doxorubicin—stomach cancer	0.000288	0.000751	CcSEcCtD
Methylprednisolone—Visual impairment—Methotrexate—stomach cancer	0.000287	0.00075	CcSEcCtD
Methylprednisolone—Confusional state—Capecitabine—stomach cancer	0.000287	0.000749	CcSEcCtD
Methylprednisolone—Tachycardia—Docetaxel—stomach cancer	0.000287	0.000749	CcSEcCtD
Methylprednisolone—Skin disorder—Docetaxel—stomach cancer	0.000286	0.000745	CcSEcCtD
Methylprednisolone—Bradycardia—Epirubicin—stomach cancer	0.000284	0.000742	CcSEcCtD
Methylprednisolone—Infection—Capecitabine—stomach cancer	0.000283	0.000738	CcSEcCtD
Methylprednisolone—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000282	0.000736	CcSEcCtD
Methylprednisolone—Dizziness—Irinotecan—stomach cancer	0.000281	0.000734	CcSEcCtD
Methylprednisolone—Haemoglobin—Epirubicin—stomach cancer	0.000281	0.000732	CcSEcCtD
Methylprednisolone—Shock—Capecitabine—stomach cancer	0.00028	0.000731	CcSEcCtD
Methylprednisolone—Rhinitis—Epirubicin—stomach cancer	0.00028	0.00073	CcSEcCtD
Methylprednisolone—Nervous system disorder—Capecitabine—stomach cancer	0.000279	0.000729	CcSEcCtD
Methylprednisolone—Haemorrhage—Epirubicin—stomach cancer	0.000279	0.000728	CcSEcCtD
Methylprednisolone—Eye disorder—Methotrexate—stomach cancer	0.000279	0.000727	CcSEcCtD
Methylprednisolone—Diarrhoea—Fluorouracil—stomach cancer	0.000279	0.000727	CcSEcCtD
Methylprednisolone—Tachycardia—Capecitabine—stomach cancer	0.000278	0.000725	CcSEcCtD
Methylprednisolone—Cardiac disorder—Methotrexate—stomach cancer	0.000277	0.000722	CcSEcCtD
Methylprednisolone—Skin disorder—Capecitabine—stomach cancer	0.000276	0.000722	CcSEcCtD
Methylprednisolone—Sweating—Doxorubicin—stomach cancer	0.000276	0.00072	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Capecitabine—stomach cancer	0.000275	0.000718	CcSEcCtD
Methylprednisolone—Hypotension—Docetaxel—stomach cancer	0.000275	0.000717	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Epirubicin—stomach cancer	0.000274	0.000716	CcSEcCtD
Methylprednisolone—Triamcinolone—PTGS2—stomach cancer	0.000271	0.0511	CrCbGaD
Methylprednisolone—Angiopathy—Methotrexate—stomach cancer	0.000271	0.000706	CcSEcCtD
Methylprednisolone—Vomiting—Irinotecan—stomach cancer	0.00027	0.000706	CcSEcCtD
Methylprednisolone—Immune system disorder—Methotrexate—stomach cancer	0.000269	0.000703	CcSEcCtD
Methylprednisolone—Dizziness—Fluorouracil—stomach cancer	0.000269	0.000703	CcSEcCtD
Methylprednisolone—Visual impairment—Epirubicin—stomach cancer	0.000269	0.000702	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Methotrexate—stomach cancer	0.000269	0.000702	CcSEcCtD
Methylprednisolone—Rash—Irinotecan—stomach cancer	0.000268	0.0007	CcSEcCtD
Methylprednisolone—Dermatitis—Irinotecan—stomach cancer	0.000268	0.000699	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000268	0.000699	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SMAD4—stomach cancer	0.000268	0.00502	CbGpPWpGaD
Methylprednisolone—Headache—Irinotecan—stomach cancer	0.000266	0.000695	CcSEcCtD
Methylprednisolone—Hypotension—Capecitabine—stomach cancer	0.000266	0.000694	CcSEcCtD
Methylprednisolone—Insomnia—Docetaxel—stomach cancer	0.000266	0.000694	CcSEcCtD
Methylprednisolone—Paraesthesia—Docetaxel—stomach cancer	0.000264	0.000689	CcSEcCtD
Methylprednisolone—Bradycardia—Doxorubicin—stomach cancer	0.000263	0.000686	CcSEcCtD
Methylprednisolone—Mental disorder—Methotrexate—stomach cancer	0.000261	0.000682	CcSEcCtD
Methylprednisolone—Eye disorder—Epirubicin—stomach cancer	0.000261	0.000681	CcSEcCtD
Methylprednisolone—CYP3A4—Irinotecan Pathway—APC—stomach cancer	0.00026	0.00488	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—IL10—stomach cancer	0.00026	0.00487	CbGpPWpGaD
Methylprednisolone—Erythema—Methotrexate—stomach cancer	0.00026	0.000678	CcSEcCtD
Methylprednisolone—Malnutrition—Methotrexate—stomach cancer	0.00026	0.000678	CcSEcCtD
Methylprednisolone—Haemoglobin—Doxorubicin—stomach cancer	0.00026	0.000677	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000259	0.000677	CcSEcCtD
Methylprednisolone—Cardiac disorder—Epirubicin—stomach cancer	0.000259	0.000676	CcSEcCtD
Methylprednisolone—Vomiting—Fluorouracil—stomach cancer	0.000259	0.000676	CcSEcCtD
Methylprednisolone—Rhinitis—Doxorubicin—stomach cancer	0.000259	0.000676	CcSEcCtD
Methylprednisolone—Dyspepsia—Docetaxel—stomach cancer	0.000259	0.000675	CcSEcCtD
Methylprednisolone—Haemorrhage—Doxorubicin—stomach cancer	0.000258	0.000674	CcSEcCtD
Methylprednisolone—Insomnia—Capecitabine—stomach cancer	0.000257	0.000672	CcSEcCtD
Methylprednisolone—Rash—Fluorouracil—stomach cancer	0.000257	0.00067	CcSEcCtD
Methylprednisolone—Dermatitis—Fluorouracil—stomach cancer	0.000257	0.00067	CcSEcCtD
Methylprednisolone—Paraesthesia—Capecitabine—stomach cancer	0.000256	0.000667	CcSEcCtD
Methylprednisolone—Headache—Fluorouracil—stomach cancer	0.000255	0.000666	CcSEcCtD
Methylprednisolone—Connective tissue disorder—Doxorubicin—stomach cancer	0.000254	0.000662	CcSEcCtD
Methylprednisolone—Fatigue—Docetaxel—stomach cancer	0.000253	0.000662	CcSEcCtD
Methylprednisolone—Angiopathy—Epirubicin—stomach cancer	0.000253	0.000661	CcSEcCtD
Methylprednisolone—Nausea—Irinotecan—stomach cancer	0.000253	0.000659	CcSEcCtD
Methylprednisolone—Immune system disorder—Epirubicin—stomach cancer	0.000252	0.000658	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Epirubicin—stomach cancer	0.000252	0.000657	CcSEcCtD
Methylprednisolone—Dyspepsia—Capecitabine—stomach cancer	0.000251	0.000654	CcSEcCtD
Methylprednisolone—Arrhythmia—Epirubicin—stomach cancer	0.000249	0.000651	CcSEcCtD
Methylprednisolone—Visual impairment—Doxorubicin—stomach cancer	0.000249	0.00065	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TFF1—stomach cancer	0.000248	0.00465	CbGpPWpGaD
Methylprednisolone—Fatigue—Capecitabine—stomach cancer	0.000245	0.00064	CcSEcCtD
Methylprednisolone—NR3C1—Adipogenesis—GADD45A—stomach cancer	0.000245	0.00458	CbGpPWpGaD
Methylprednisolone—Mental disorder—Epirubicin—stomach cancer	0.000245	0.000638	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—PLAU—stomach cancer	0.000244	0.00457	CbGpPWpGaD
Methylprednisolone—Malnutrition—Epirubicin—stomach cancer	0.000243	0.000634	CcSEcCtD
Methylprednisolone—Erythema—Epirubicin—stomach cancer	0.000243	0.000634	CcSEcCtD
Methylprednisolone—Feeling abnormal—Docetaxel—stomach cancer	0.000242	0.000632	CcSEcCtD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—ENO1—stomach cancer	0.000242	0.00454	CbGpPWpGaD
Methylprednisolone—Nausea—Fluorouracil—stomach cancer	0.000242	0.000631	CcSEcCtD
Methylprednisolone—Eye disorder—Doxorubicin—stomach cancer	0.000241	0.00063	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Methotrexate—stomach cancer	0.000241	0.000629	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Docetaxel—stomach cancer	0.00024	0.000627	CcSEcCtD
Methylprednisolone—Cardiac disorder—Doxorubicin—stomach cancer	0.00024	0.000626	CcSEcCtD
Methylprednisolone—Feeling abnormal—Capecitabine—stomach cancer	0.000235	0.000612	CcSEcCtD
Methylprednisolone—Angiopathy—Doxorubicin—stomach cancer	0.000234	0.000612	CcSEcCtD
Methylprednisolone—Malaise—Methotrexate—stomach cancer	0.000234	0.000611	CcSEcCtD
Methylprednisolone—Immune system disorder—Doxorubicin—stomach cancer	0.000233	0.000609	CcSEcCtD
Methylprednisolone—Vertigo—Methotrexate—stomach cancer	0.000233	0.000609	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Capecitabine—stomach cancer	0.000233	0.000607	CcSEcCtD
Methylprednisolone—Mediastinal disorder—Doxorubicin—stomach cancer	0.000233	0.000607	CcSEcCtD
Methylprednisolone—Abdominal pain—Docetaxel—stomach cancer	0.000232	0.000607	CcSEcCtD
Methylprednisolone—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—stomach cancer	0.000231	0.00433	CbGpPWpGaD
Methylprednisolone—Arrhythmia—Doxorubicin—stomach cancer	0.000231	0.000602	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—HTR1A—stomach cancer	0.00023	0.00431	CbGpPWpGaD
Methylprednisolone—NR3C1—Circadian Clock—SERPINE1—stomach cancer	0.000229	0.00429	CbGpPWpGaD
Methylprednisolone—NR3C1—Transcription factor regulation in adipogenesis—IL6—stomach cancer	0.000227	0.00425	CbGpPWpGaD
Methylprednisolone—Mental disorder—Doxorubicin—stomach cancer	0.000226	0.000591	CcSEcCtD
Methylprednisolone—Urticaria—Capecitabine—stomach cancer	0.000226	0.00059	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Epirubicin—stomach cancer	0.000225	0.000588	CcSEcCtD
Methylprednisolone—Abdominal pain—Capecitabine—stomach cancer	0.000225	0.000587	CcSEcCtD
Methylprednisolone—Convulsion—Methotrexate—stomach cancer	0.000225	0.000587	CcSEcCtD
Methylprednisolone—Erythema—Doxorubicin—stomach cancer	0.000225	0.000587	CcSEcCtD
Methylprednisolone—Malnutrition—Doxorubicin—stomach cancer	0.000225	0.000587	CcSEcCtD
Methylprednisolone—NR3C1—Endoderm Differentiation—APC—stomach cancer	0.000222	0.00416	CbGpPWpGaD
Methylprednisolone—Betamethasone—PTGS2—stomach cancer	0.000222	0.0419	CrCbGaD
Methylprednisolone—Arthralgia—Methotrexate—stomach cancer	0.000221	0.000577	CcSEcCtD
Methylprednisolone—Myalgia—Methotrexate—stomach cancer	0.000221	0.000577	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.00022	0.000573	CcSEcCtD
Methylprednisolone—Malaise—Epirubicin—stomach cancer	0.000219	0.000572	CcSEcCtD
Methylprednisolone—Prednisone—ALB—stomach cancer	0.000219	0.0413	CrCbGaD
Methylprednisolone—Discomfort—Methotrexate—stomach cancer	0.000218	0.00057	CcSEcCtD
Methylprednisolone—Vertigo—Epirubicin—stomach cancer	0.000218	0.00057	CcSEcCtD
Methylprednisolone—Syncope—Epirubicin—stomach cancer	0.000218	0.000569	CcSEcCtD
Methylprednisolone—ABCB1—ABC-family proteins mediated transport—APOA1—stomach cancer	0.000217	0.00407	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Docetaxel—stomach cancer	0.000217	0.000565	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL1RN—stomach cancer	0.000215	0.00403	CbGpPWpGaD
Methylprednisolone—Confusional state—Methotrexate—stomach cancer	0.000214	0.000558	CcSEcCtD
Methylprednisolone—Loss of consciousness—Epirubicin—stomach cancer	0.000214	0.000557	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Methotrexate—stomach cancer	0.000212	0.000553	CcSEcCtD
Methylprednisolone—Asthenia—Docetaxel—stomach cancer	0.000211	0.000551	CcSEcCtD
Methylprednisolone—Convulsion—Epirubicin—stomach cancer	0.000211	0.000549	CcSEcCtD
Methylprednisolone—Infection—Methotrexate—stomach cancer	0.000211	0.000549	CcSEcCtD
Methylprednisolone—Hypertension—Epirubicin—stomach cancer	0.00021	0.000548	CcSEcCtD
Methylprednisolone—Hypersensitivity—Capecitabine—stomach cancer	0.00021	0.000547	CcSEcCtD
Methylprednisolone—Ill-defined disorder—Doxorubicin—stomach cancer	0.000209	0.000544	CcSEcCtD
Methylprednisolone—Pruritus—Docetaxel—stomach cancer	0.000208	0.000543	CcSEcCtD
Methylprednisolone—Nervous system disorder—Methotrexate—stomach cancer	0.000208	0.000542	CcSEcCtD
Methylprednisolone—Myalgia—Epirubicin—stomach cancer	0.000207	0.00054	CcSEcCtD
Methylprednisolone—Arthralgia—Epirubicin—stomach cancer	0.000207	0.00054	CcSEcCtD
Methylprednisolone—Anxiety—Epirubicin—stomach cancer	0.000206	0.000538	CcSEcCtD
Methylprednisolone—Skin disorder—Methotrexate—stomach cancer	0.000206	0.000537	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.000205	0.000536	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDK4—stomach cancer	0.000205	0.00384	CbGpPWpGaD
Methylprednisolone—Hyperhidrosis—Methotrexate—stomach cancer	0.000205	0.000535	CcSEcCtD
Methylprednisolone—Discomfort—Epirubicin—stomach cancer	0.000204	0.000533	CcSEcCtD
Methylprednisolone—Asthenia—Capecitabine—stomach cancer	0.000204	0.000533	CcSEcCtD
Methylprednisolone—Malaise—Doxorubicin—stomach cancer	0.000203	0.000529	CcSEcCtD
Methylprednisolone—Vertigo—Doxorubicin—stomach cancer	0.000202	0.000527	CcSEcCtD
Methylprednisolone—Syncope—Doxorubicin—stomach cancer	0.000202	0.000526	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—ZNF559—stomach cancer	0.000201	0.00377	CbGpPWpGaD
Methylprednisolone—Pruritus—Capecitabine—stomach cancer	0.000201	0.000526	CcSEcCtD
Methylprednisolone—Diarrhoea—Docetaxel—stomach cancer	0.000201	0.000525	CcSEcCtD
Methylprednisolone—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.0002	0.00376	CbGpPWpGaD
Methylprednisolone—Confusional state—Epirubicin—stomach cancer	0.0002	0.000522	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Epirubicin—stomach cancer	0.000198	0.000518	CcSEcCtD
Methylprednisolone—Hypotension—Methotrexate—stomach cancer	0.000198	0.000517	CcSEcCtD
Methylprednisolone—Loss of consciousness—Doxorubicin—stomach cancer	0.000198	0.000516	CcSEcCtD
Methylprednisolone—Infection—Epirubicin—stomach cancer	0.000197	0.000514	CcSEcCtD
Methylprednisolone—Shock—Epirubicin—stomach cancer	0.000195	0.000509	CcSEcCtD
Methylprednisolone—Convulsion—Doxorubicin—stomach cancer	0.000195	0.000508	CcSEcCtD
Methylprednisolone—Diarrhoea—Capecitabine—stomach cancer	0.000195	0.000508	CcSEcCtD
Methylprednisolone—Nervous system disorder—Epirubicin—stomach cancer	0.000194	0.000508	CcSEcCtD
Methylprednisolone—Dizziness—Docetaxel—stomach cancer	0.000194	0.000507	CcSEcCtD
Methylprednisolone—Hypertension—Doxorubicin—stomach cancer	0.000194	0.000507	CcSEcCtD
Methylprednisolone—Tachycardia—Epirubicin—stomach cancer	0.000194	0.000505	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.000193	0.000504	CcSEcCtD
Methylprednisolone—Skin disorder—Epirubicin—stomach cancer	0.000193	0.000503	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Epirubicin—stomach cancer	0.000192	0.0005	CcSEcCtD
Methylprednisolone—Insomnia—Methotrexate—stomach cancer	0.000192	0.0005	CcSEcCtD
Methylprednisolone—Myalgia—Doxorubicin—stomach cancer	0.000191	0.0005	CcSEcCtD
Methylprednisolone—Arthralgia—Doxorubicin—stomach cancer	0.000191	0.0005	CcSEcCtD
Methylprednisolone—Anxiety—Doxorubicin—stomach cancer	0.000191	0.000498	CcSEcCtD
Methylprednisolone—Paraesthesia—Methotrexate—stomach cancer	0.00019	0.000497	CcSEcCtD
Methylprednisolone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.00019	0.000496	CcSEcCtD
Methylprednisolone—Discomfort—Doxorubicin—stomach cancer	0.000189	0.000494	CcSEcCtD
Methylprednisolone—Dizziness—Capecitabine—stomach cancer	0.000188	0.000491	CcSEcCtD
Methylprednisolone—Vomiting—Docetaxel—stomach cancer	0.000187	0.000488	CcSEcCtD
Methylprednisolone—Dyspepsia—Methotrexate—stomach cancer	0.000187	0.000487	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of Androgen receptor activity—JUN—stomach cancer	0.000186	0.00348	CbGpPWpGaD
Methylprednisolone—Rash—Docetaxel—stomach cancer	0.000185	0.000484	CcSEcCtD
Methylprednisolone—Hypotension—Epirubicin—stomach cancer	0.000185	0.000484	CcSEcCtD
Methylprednisolone—Dermatitis—Docetaxel—stomach cancer	0.000185	0.000483	CcSEcCtD
Methylprednisolone—Confusional state—Doxorubicin—stomach cancer	0.000185	0.000483	CcSEcCtD
Methylprednisolone—Headache—Docetaxel—stomach cancer	0.000184	0.000481	CcSEcCtD
Methylprednisolone—Anaphylactic shock—Doxorubicin—stomach cancer	0.000183	0.000479	CcSEcCtD
Methylprednisolone—Fatigue—Methotrexate—stomach cancer	0.000183	0.000477	CcSEcCtD
Methylprednisolone—Infection—Doxorubicin—stomach cancer	0.000182	0.000476	CcSEcCtD
Methylprednisolone—Vomiting—Capecitabine—stomach cancer	0.000181	0.000472	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000181	0.000472	CcSEcCtD
Methylprednisolone—Shock—Doxorubicin—stomach cancer	0.000181	0.000471	CcSEcCtD
Methylprednisolone—Nervous system disorder—Doxorubicin—stomach cancer	0.00018	0.00047	CcSEcCtD
Methylprednisolone—Rash—Capecitabine—stomach cancer	0.000179	0.000468	CcSEcCtD
Methylprednisolone—Insomnia—Epirubicin—stomach cancer	0.000179	0.000468	CcSEcCtD
Methylprednisolone—Dermatitis—Capecitabine—stomach cancer	0.000179	0.000468	CcSEcCtD
Methylprednisolone—Tachycardia—Doxorubicin—stomach cancer	0.000179	0.000467	CcSEcCtD
Methylprednisolone—Headache—Capecitabine—stomach cancer	0.000178	0.000465	CcSEcCtD
Methylprednisolone—Skin disorder—Doxorubicin—stomach cancer	0.000178	0.000465	CcSEcCtD
Methylprednisolone—Paraesthesia—Epirubicin—stomach cancer	0.000178	0.000465	CcSEcCtD
Methylprednisolone—Hyperhidrosis—Doxorubicin—stomach cancer	0.000177	0.000463	CcSEcCtD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—HMOX1—stomach cancer	0.000177	0.00331	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CDKN2A—stomach cancer	0.000176	0.0033	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of Androgen receptor activity—MAPK8—stomach cancer	0.000176	0.00329	CbGpPWpGaD
Methylprednisolone—Nausea—Docetaxel—stomach cancer	0.000175	0.000456	CcSEcCtD
Methylprednisolone—Feeling abnormal—Methotrexate—stomach cancer	0.000175	0.000456	CcSEcCtD
Methylprednisolone—Dyspepsia—Epirubicin—stomach cancer	0.000175	0.000456	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Methotrexate—stomach cancer	0.000173	0.000452	CcSEcCtD
Methylprednisolone—Hypotension—Doxorubicin—stomach cancer	0.000171	0.000447	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—PRPF19—stomach cancer	0.000171	0.00321	CbGpPWpGaD
Methylprednisolone—Fatigue—Epirubicin—stomach cancer	0.000171	0.000446	CcSEcCtD
Methylprednisolone—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2A6—stomach cancer	0.00017	0.00318	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—SMAD4—stomach cancer	0.000169	0.00318	CbGpPWpGaD
Methylprednisolone—Nausea—Capecitabine—stomach cancer	0.000169	0.000441	CcSEcCtD
Methylprednisolone—Urticaria—Methotrexate—stomach cancer	0.000168	0.000439	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—SERPINE1—stomach cancer	0.000168	0.00315	CbGpPWpGaD
Methylprednisolone—CYP3A4—Oxidation by Cytochrome P450—CYP2A6—stomach cancer	0.000168	0.00314	CbGpPWpGaD
Methylprednisolone—Abdominal pain—Methotrexate—stomach cancer	0.000168	0.000437	CcSEcCtD
Methylprednisolone—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.000167	0.000436	CcSEcCtD
Methylprednisolone—NR3C1—Generic Transcription Pathway—RXRB—stomach cancer	0.000167	0.00312	CbGpPWpGaD
Methylprednisolone—Insomnia—Doxorubicin—stomach cancer	0.000166	0.000433	CcSEcCtD
Methylprednisolone—Paraesthesia—Doxorubicin—stomach cancer	0.000165	0.00043	CcSEcCtD
Methylprednisolone—Feeling abnormal—Epirubicin—stomach cancer	0.000163	0.000426	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BID—stomach cancer	0.000162	0.00304	CbGpPWpGaD
Methylprednisolone—Gastrointestinal pain—Epirubicin—stomach cancer	0.000162	0.000423	CcSEcCtD
Methylprednisolone—Dyspepsia—Doxorubicin—stomach cancer	0.000162	0.000422	CcSEcCtD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—BDNF—stomach cancer	0.000161	0.00302	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CXCL8—stomach cancer	0.00016	0.00299	CbGpPWpGaD
Methylprednisolone—Fatigue—Doxorubicin—stomach cancer	0.000158	0.000413	CcSEcCtD
Methylprednisolone—Urticaria—Epirubicin—stomach cancer	0.000158	0.000411	CcSEcCtD
Methylprednisolone—Abdominal pain—Epirubicin—stomach cancer	0.000157	0.000409	CcSEcCtD
Methylprednisolone—Hypersensitivity—Methotrexate—stomach cancer	0.000156	0.000407	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CDKN1B—stomach cancer	0.000156	0.00292	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL10—stomach cancer	0.000154	0.00288	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—CLCN3—stomach cancer	0.000153	0.00286	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ZNF160—stomach cancer	0.000153	0.00286	CbGpPWpGaD
Methylprednisolone—Asthenia—Methotrexate—stomach cancer	0.000152	0.000397	CcSEcCtD
Methylprednisolone—Feeling abnormal—Doxorubicin—stomach cancer	0.000151	0.000395	CcSEcCtD
Methylprednisolone—Gastrointestinal pain—Doxorubicin—stomach cancer	0.00015	0.000392	CcSEcCtD
Methylprednisolone—Pruritus—Methotrexate—stomach cancer	0.00015	0.000391	CcSEcCtD
Methylprednisolone—NR3C1—Adipogenesis—IRS2—stomach cancer	0.00015	0.00281	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—FST—stomach cancer	0.000149	0.0028	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP10—stomach cancer	0.000149	0.0028	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—CCND1—stomach cancer	0.000149	0.00279	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—JUN—stomach cancer	0.000149	0.00278	CbGpPWpGaD
Methylprednisolone—Hypersensitivity—Epirubicin—stomach cancer	0.000146	0.000381	CcSEcCtD
Methylprednisolone—Urticaria—Doxorubicin—stomach cancer	0.000146	0.00038	CcSEcCtD
Methylprednisolone—Abdominal pain—Doxorubicin—stomach cancer	0.000145	0.000379	CcSEcCtD
Methylprednisolone—Diarrhoea—Methotrexate—stomach cancer	0.000145	0.000378	CcSEcCtD
Methylprednisolone—NR3C1—AP-1 transcription factor network—MMP9—stomach cancer	0.000144	0.00271	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL10—stomach cancer	0.000142	0.00267	CbGpPWpGaD
Methylprednisolone—Asthenia—Epirubicin—stomach cancer	0.000142	0.000371	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—CXCL8—stomach cancer	0.000141	0.00264	CbGpPWpGaD
Methylprednisolone—Pruritus—Epirubicin—stomach cancer	0.00014	0.000366	CcSEcCtD
Methylprednisolone—Dizziness—Methotrexate—stomach cancer	0.00014	0.000366	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—EEF1A2—stomach cancer	0.00014	0.00262	CbGpPWpGaD
Methylprednisolone—CYP3A4—Phase 1 - Functionalization of compounds—CYP2A6—stomach cancer	0.000138	0.00258	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IL6ST—stomach cancer	0.000138	0.00258	CbGpPWpGaD
Methylprednisolone—Diarrhoea—Epirubicin—stomach cancer	0.000136	0.000354	CcSEcCtD
Methylprednisolone—Hypersensitivity—Doxorubicin—stomach cancer	0.000135	0.000353	CcSEcCtD
Methylprednisolone—Vomiting—Methotrexate—stomach cancer	0.000135	0.000352	CcSEcCtD
Methylprednisolone—NR3C1—Generic Transcription Pathway—RORA—stomach cancer	0.000135	0.00252	CbGpPWpGaD
Methylprednisolone—Rash—Methotrexate—stomach cancer	0.000134	0.000349	CcSEcCtD
Methylprednisolone—Dermatitis—Methotrexate—stomach cancer	0.000133	0.000348	CcSEcCtD
Methylprednisolone—Headache—Methotrexate—stomach cancer	0.000133	0.000346	CcSEcCtD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—JUN—stomach cancer	0.000132	0.00248	CbGpPWpGaD
Methylprednisolone—Asthenia—Doxorubicin—stomach cancer	0.000132	0.000344	CcSEcCtD
Methylprednisolone—Dizziness—Epirubicin—stomach cancer	0.000131	0.000342	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—JUN—stomach cancer	0.000131	0.00245	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—RARB—stomach cancer	0.00013	0.00244	CbGpPWpGaD
Methylprednisolone—Pruritus—Doxorubicin—stomach cancer	0.00013	0.000339	CcSEcCtD
Methylprednisolone—Dexamethasone—PTGS2—stomach cancer	0.000129	0.0244	CrCbGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—CDKN1A—stomach cancer	0.000128	0.0024	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—PPARG—stomach cancer	0.000128	0.00239	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—CDKN1A—stomach cancer	0.000127	0.00238	CbGpPWpGaD
Methylprednisolone—Vomiting—Epirubicin—stomach cancer	0.000126	0.000329	CcSEcCtD
Methylprednisolone—Nausea—Methotrexate—stomach cancer	0.000126	0.000328	CcSEcCtD
Methylprednisolone—Diarrhoea—Doxorubicin—stomach cancer	0.000126	0.000328	CcSEcCtD
Methylprednisolone—Rash—Epirubicin—stomach cancer	0.000125	0.000326	CcSEcCtD
Methylprednisolone—Dermatitis—Epirubicin—stomach cancer	0.000125	0.000326	CcSEcCtD
Methylprednisolone—Headache—Epirubicin—stomach cancer	0.000124	0.000324	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK8—stomach cancer	0.000124	0.00232	CbGpPWpGaD
Methylprednisolone—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—stomach cancer	0.000124	0.00231	CbGpPWpGaD
Methylprednisolone—Dizziness—Doxorubicin—stomach cancer	0.000121	0.000317	CcSEcCtD
Methylprednisolone—NR3C1—Generic Transcription Pathway—RARB—stomach cancer	0.00012	0.00226	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—MYC—stomach cancer	0.000119	0.00224	CbGpPWpGaD
Methylprednisolone—Nausea—Epirubicin—stomach cancer	0.000118	0.000307	CcSEcCtD
Methylprednisolone—Vomiting—Doxorubicin—stomach cancer	0.000117	0.000304	CcSEcCtD
Methylprednisolone—Rash—Doxorubicin—stomach cancer	0.000116	0.000302	CcSEcCtD
Methylprednisolone—NR3C1—Gene Expression—HNRNPL—stomach cancer	0.000116	0.00217	CbGpPWpGaD
Methylprednisolone—Dermatitis—Doxorubicin—stomach cancer	0.000116	0.000302	CcSEcCtD
Methylprednisolone—NR3C1—Adipogenesis—SERPINE1—stomach cancer	0.000115	0.00215	CbGpPWpGaD
Methylprednisolone—Headache—Doxorubicin—stomach cancer	0.000115	0.0003	CcSEcCtD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—stomach cancer	0.000113	0.00212	CbGpPWpGaD
Methylprednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDKN1B—stomach cancer	0.000111	0.00209	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—EEF1A1—stomach cancer	0.00011	0.00207	CbGpPWpGaD
Methylprednisolone—Nausea—Doxorubicin—stomach cancer	0.000109	0.000284	CcSEcCtD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK3—stomach cancer	0.000108	0.00203	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—SERPINE1—stomach cancer	0.000106	0.00199	CbGpPWpGaD
Methylprednisolone—NR3C1—Regulation of nuclear SMAD2/3 signaling—MYC—stomach cancer	0.000106	0.00199	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL6R—stomach cancer	0.000106	0.00199	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—MAPK1—stomach cancer	0.000103	0.00193	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ANXA1—stomach cancer	0.000101	0.0019	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CASP8—stomach cancer	9.85e-05	0.00185	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—TP53—stomach cancer	9.8e-05	0.00184	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—GADD45A—stomach cancer	9.66e-05	0.00181	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—EXOSC5—stomach cancer	9.53e-05	0.00179	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—CPSF1—stomach cancer	9.53e-05	0.00179	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—POLR3K—stomach cancer	9.25e-05	0.00173	CbGpPWpGaD
Methylprednisolone—NR3C1—AP-1 transcription factor network—IL6—stomach cancer	8.97e-05	0.00168	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	8.83e-05	0.00165	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—CDKN1A—stomach cancer	8.77e-05	0.00164	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—TP53—stomach cancer	8.64e-05	0.00162	CbGpPWpGaD
Methylprednisolone—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—stomach cancer	8.53e-05	0.0016	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—CXCL8—stomach cancer	8.41e-05	0.00158	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—JUN—stomach cancer	8.36e-05	0.00157	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL1B—stomach cancer	8.07e-05	0.00151	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RXRB—stomach cancer	8.02e-05	0.0015	CbGpPWpGaD
Methylprednisolone—NR3C1—Glucocorticoid receptor regulatory network—IL6—stomach cancer	7.91e-05	0.00148	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RPL13—stomach cancer	7.86e-05	0.00147	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RPL18—stomach cancer	7.86e-05	0.00147	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—STAT3—stomach cancer	7.83e-05	0.00147	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—JUN—stomach cancer	7.82e-05	0.00147	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—CXCL8—stomach cancer	7.79e-05	0.00146	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—IL1B—stomach cancer	7.47e-05	0.0014	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTT1—stomach cancer	7.4e-05	0.00139	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	7.37e-05	0.00138	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RPS21—stomach cancer	7.33e-05	0.00137	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RPS15—stomach cancer	7.33e-05	0.00137	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—CYP2A6—stomach cancer	7.31e-05	0.00137	CbGpPWpGaD
Methylprednisolone—ABCB1—HIF-1-alpha transcription factor network—VEGFA—stomach cancer	7.31e-05	0.00137	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	7.24e-05	0.00136	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SNRPB—stomach cancer	7.22e-05	0.00135	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ACAD8—stomach cancer	7.15e-05	0.00134	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	7.11e-05	0.00133	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—AKR1C3—stomach cancer	7.01e-05	0.00131	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—stomach cancer	6.83e-05	0.00128	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—TNF—stomach cancer	6.78e-05	0.00127	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—SMAD4—stomach cancer	6.7e-05	0.00126	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	6.65e-05	0.00125	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RORA—stomach cancer	6.48e-05	0.00122	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GMPR2—stomach cancer	6.38e-05	0.0012	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—VEGFA—stomach cancer	6.33e-05	0.00119	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—DNMT3B—stomach cancer	6.08e-05	0.00114	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RPL15—stomach cancer	5.96e-05	0.00112	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—TNF—stomach cancer	5.86e-05	0.0011	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SUCLG1—stomach cancer	5.83e-05	0.00109	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—IDH3B—stomach cancer	5.83e-05	0.00109	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RARB—stomach cancer	5.8e-05	0.00109	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RPS26—stomach cancer	5.56e-05	0.00104	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	5.55e-05	0.00104	CbGpPWpGaD
Methylprednisolone—NR3C1—Adipogenesis—IL6—stomach cancer	5.47e-05	0.00102	CbGpPWpGaD
Methylprednisolone—ABCB1—Allograft Rejection—TNF—stomach cancer	5.42e-05	0.00102	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NDUFV1—stomach cancer	5.42e-05	0.00102	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NDUFS1—stomach cancer	5.42e-05	0.00102	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	5.22e-05	0.000979	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTP1—stomach cancer	5.13e-05	0.000961	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTP1—stomach cancer	5.06e-05	0.000948	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	4.86e-05	0.000911	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—HSPB1—stomach cancer	4.86e-05	0.00091	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PGLS—stomach cancer	4.83e-05	0.000906	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—BLVRB—stomach cancer	4.83e-05	0.000906	CbGpPWpGaD
Methylprednisolone—NR3C1—SIDS Susceptibility Pathways—IL6—stomach cancer	4.73e-05	0.000886	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RPS19—stomach cancer	4.73e-05	0.000886	CbGpPWpGaD
Methylprednisolone—CYP3A4—Biological oxidations—GSTM1—stomach cancer	4.71e-05	0.000883	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—PPARG—stomach cancer	4.66e-05	0.000873	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metapathway biotransformation—GSTM1—stomach cancer	4.65e-05	0.000871	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPAP2A—stomach cancer	4.61e-05	0.000864	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—DNMT1—stomach cancer	4.52e-05	0.000846	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—HSPA8—stomach cancer	4.45e-05	0.000835	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ACAD8—stomach cancer	4.41e-05	0.000826	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—SERPINE1—stomach cancer	4.2e-05	0.000787	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—RPS6—stomach cancer	4.18e-05	0.000783	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CA1—stomach cancer	4.11e-05	0.00077	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—FBP1—stomach cancer	4.11e-05	0.00077	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CKB—stomach cancer	4.11e-05	0.00077	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NDUFA2—stomach cancer	4.11e-05	0.00077	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	4.05e-05	0.00076	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	3.96e-05	0.000743	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GMPR2—stomach cancer	3.93e-05	0.000736	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PLIN2—stomach cancer	3.86e-05	0.000724	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CA2—stomach cancer	3.76e-05	0.000704	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	3.75e-05	0.000704	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NT5E—stomach cancer	3.66e-05	0.000686	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PGAM1—stomach cancer	3.66e-05	0.000686	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SUCLG1—stomach cancer	3.59e-05	0.000673	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—IDH3B—stomach cancer	3.59e-05	0.000673	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	3.58e-05	0.000671	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	3.57e-05	0.00067	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALDH7A1—stomach cancer	3.49e-05	0.000655	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PLCE1—stomach cancer	3.49e-05	0.000655	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PPP2R1A—stomach cancer	3.47e-05	0.000651	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	3.47e-05	0.000649	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	3.38e-05	0.000634	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—UMPS—stomach cancer	3.35e-05	0.000628	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NDUFS1—stomach cancer	3.34e-05	0.000626	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NDUFV1—stomach cancer	3.34e-05	0.000626	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SMAD4—stomach cancer	3.22e-05	0.000604	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	3.12e-05	0.000585	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PDHA1—stomach cancer	3.11e-05	0.000584	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ECHS1—stomach cancer	3.11e-05	0.000584	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	3e-05	0.000562	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PGLS—stomach cancer	2.98e-05	0.000558	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—BLVRB—stomach cancer	2.98e-05	0.000558	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	2.95e-05	0.000554	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—ERCC2—stomach cancer	2.94e-05	0.000552	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—TYMP—stomach cancer	2.93e-05	0.000549	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—FADS1—stomach cancer	2.93e-05	0.000549	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	2.87e-05	0.000538	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPAP2A—stomach cancer	2.84e-05	0.000532	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	2.81e-05	0.000527	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	2.81e-05	0.000527	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—SREBF2—stomach cancer	2.74e-05	0.000514	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—RORA—stomach cancer	2.71e-05	0.000508	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	2.68e-05	0.000502	CbGpPWpGaD
Methylprednisolone—NR3C1—Generic Transcription Pathway—MYC—stomach cancer	2.66e-05	0.000498	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	2.65e-05	0.000498	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALDOB—stomach cancer	2.54e-05	0.000476	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CA1—stomach cancer	2.53e-05	0.000474	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CKB—stomach cancer	2.53e-05	0.000474	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—FBP1—stomach cancer	2.53e-05	0.000474	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NDUFA2—stomach cancer	2.53e-05	0.000474	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	2.44e-05	0.000457	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PLIN2—stomach cancer	2.38e-05	0.000446	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALOX5—stomach cancer	2.36e-05	0.000442	CbGpPWpGaD
Methylprednisolone—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	2.36e-05	0.000442	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—DPYD—stomach cancer	2.32e-05	0.000435	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CA2—stomach cancer	2.32e-05	0.000434	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	2.27e-05	0.000426	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NT5E—stomach cancer	2.26e-05	0.000423	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PGAM1—stomach cancer	2.26e-05	0.000423	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—PPARG—stomach cancer	2.24e-05	0.00042	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PLCE1—stomach cancer	2.15e-05	0.000403	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALDH7A1—stomach cancer	2.15e-05	0.000403	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—UMPS—stomach cancer	2.06e-05	0.000387	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTT1—stomach cancer	2.05e-05	0.000385	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CYP2A6—stomach cancer	2.03e-05	0.00038	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—SERPINE1—stomach cancer	2.02e-05	0.000379	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—AKR1C3—stomach cancer	1.97e-05	0.00037	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ENO1—stomach cancer	1.92e-05	0.000361	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PDHA1—stomach cancer	1.92e-05	0.00036	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ECHS1—stomach cancer	1.92e-05	0.00036	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TYMP—stomach cancer	1.8e-05	0.000338	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—FADS1—stomach cancer	1.8e-05	0.000338	CbGpPWpGaD
Methylprednisolone—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.8e-05	0.000337	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CD44—stomach cancer	1.71e-05	0.00032	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—SREBF2—stomach cancer	1.69e-05	0.000317	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—RORA—stomach cancer	1.67e-05	0.000313	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALDOB—stomach cancer	1.56e-05	0.000293	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALOX5—stomach cancer	1.45e-05	0.000272	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPP2R1A—stomach cancer	1.45e-05	0.000272	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—DPYD—stomach cancer	1.43e-05	0.000268	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTP1—stomach cancer	1.42e-05	0.000267	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—HMOX1—stomach cancer	1.4e-05	0.000263	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—TYMS—stomach cancer	1.32e-05	0.000248	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—MAPK3—stomach cancer	1.32e-05	0.000246	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—GSTM1—stomach cancer	1.31e-05	0.000245	CbGpPWpGaD
Methylprednisolone—NR3C1—Gene Expression—MYC—stomach cancer	1.28e-05	0.00024	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTT1—stomach cancer	1.26e-05	0.000237	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CYP2A6—stomach cancer	1.25e-05	0.000234	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ERCC2—stomach cancer	1.23e-05	0.00023	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—AKR1C3—stomach cancer	1.22e-05	0.000228	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ENO1—stomach cancer	1.19e-05	0.000222	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—MTHFR—stomach cancer	1.16e-05	0.000217	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—CAV1—stomach cancer	1.07e-05	0.0002	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—APOA1—stomach cancer	1.06e-05	0.000199	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CD44—stomach cancer	1.05e-05	0.000197	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PPARG—stomach cancer	9.37e-06	0.000176	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPP2R1A—stomach cancer	8.94e-06	0.000168	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTP1—stomach cancer	8.77e-06	0.000164	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—HMOX1—stomach cancer	8.65e-06	0.000162	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—ALB—stomach cancer	8.43e-06	0.000158	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—TYMS—stomach cancer	8.15e-06	0.000153	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—NOS3—stomach cancer	8.06e-06	0.000151	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—GSTM1—stomach cancer	8.06e-06	0.000151	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ERCC2—stomach cancer	7.57e-06	0.000142	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PTGS2—stomach cancer	7.37e-06	0.000138	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—MTHFR—stomach cancer	7.12e-06	0.000133	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—CAV1—stomach cancer	6.57e-06	0.000123	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—APOA1—stomach cancer	6.55e-06	0.000123	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PPARG—stomach cancer	5.77e-06	0.000108	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—ALB—stomach cancer	5.19e-06	9.73e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—NOS3—stomach cancer	4.97e-06	9.31e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PTGS2—stomach cancer	4.54e-06	8.51e-05	CbGpPWpGaD
Methylprednisolone—ABCB1—Metabolism—PIK3CA—stomach cancer	4.54e-06	8.5e-05	CbGpPWpGaD
Methylprednisolone—CYP3A4—Metabolism—PIK3CA—stomach cancer	2.79e-06	5.24e-05	CbGpPWpGaD
